Allergy diagnostics play a dynamic role in identifying, managing, and treating allergic conditions, driving the growth of the allergy diagnostics market. These diagnostics encompass various methods, including skin tests, blood tests, and molecular diagnostics. Allergy diagnostics help healthcare providers determine the specific allergens causing an individual's allergic reactions, enabling targeted treatment plans and allergen avoidance strategies. Allergy diagnostics find extensive application in clinical settings, hospitals, and research laboratories. With the rising prevalence of allergies and the increasing awareness about allergic diseases, the demand for accurate and efficient allergy diagnostics is growing. This drives market expansion as manufacturers and healthcare providers strive to meet the growing demand for improved diagnostic tools and solutions.
According to Data Bridge Market Research the India Allergy Diagnostics Market accounted USD 4.25 billion in 2021, and is expected to reach the value of USD 9.72 billion by 2029, and is expected to undergo a CAGR of 10.9% during the forecast period 2022 to 2029.
“Increasing environmental pollution levels facilitate market growth”
Several risk factors, including indoor and outdoor air pollution exposure, allergies, and occupational hazards, influence chronic respiratory illnesses. City dwellers have a higher prevalence of allergy diseases compared to rural populations due to increased exposure to environmental contaminants resulting from vehicular pollution and industrial activities. According to the World Health Organization (WHO), over 80% of urban residents worldwide are exposed to air pollution levels exceeding safety recommendations. This trend is particularly significant in urban areas of low-income countries. The concerning levels of air pollution and the consequent rise in allergy-related health issues serve as a crucial indicator for the expanding market of allergy diagnostics, highlighting the growing need for accurate and timely diagnosis and treatment.
What restraints the growth of India allergy diagnostics market?
“Premium costs associated with allergy diagnostic instruments”
The premium costs associated with allergy diagnostic instruments significantly restrain the India allergy diagnostics market. Allergy diagnostic instruments, essential for accurate and reliable allergy testing, often come with high price tags, making them less affordable and accessible to healthcare providers and patients. The cost-sensitive nature of the Indian market, coupled with limited healthcare budgets, poses challenges for the widespread adoption and utilization of these instruments. The high upfront investment required for such equipment may discourage healthcare facilities from investing in advanced allergy diagnostic technologies, thereby limiting the growth potential of the allergy diagnostics market in India. Efforts to address affordability concerns and provide cost-effective solutions could help mitigate this restraint and promote market growth.
Segmentation: India Allergy Diagnostics Market
The India allergy diagnostics market is segmented on the basis of product, allergan, test, and end user and distribution channel.
- On the basis of products and services, the India allergy diagnostics market is segmented into assay kits, instruments, consumables and services.
- On the basis of allergen, the India allergy diagnostics market is segmented into inhaled allergens, food allergens, antibiotics, other drugs and chemicals allergens, occupational allergens, miscellaneous plant allergens, contact allergens and others.
- On the basis of test, the India allergy diagnostics market is segmented into in-vitro test and in-vivo test.
- On the basis of end user, the India allergy diagnostics market is segmented into hospitals, diagnostic laboratories, academic research laboratories and others.
- On the basis of distribution channel, the India allergy diagnostics market is segmented into direct and indirect.
To know more about the study visit https://www.databridgemarketresearch.com/de/reports/india-allergy-diagnostics-market
Recent Developments in India Allergy Diagnostics Market
- In 2021, Hitachi Chemical Diagnostics, Inc. was replaced by Minaris Medical America, Inc. This strategic move by Hitachi aims to enhance its global presence and expand commercial activities in the in-vitro diagnostics field. Through consolidating the medical business group firms under the Minaris Medical brand, Hitachi seeks to strengthen its position in the market. Both Hitachi Chemical Diagnostics and Minaris Medical America are owned by Showa Denko Materials Co., Ltd.
- In 2021, PerkinElmer Inc. reached an agreement to acquire Immunodiagnostic Systems Holdings PLC. This acquisition allows PerkinElmer Inc. to solidify its position in the ImmunoDiagnostics (IDS) industry. EUROIMMUN Medizinische LABORDIAGNOSTIKA AG, a company specializing in allergy products and services, will take over IDS as a result of the acquisition. This strategic move enables PerkinElmer Inc. to further expand its offerings and capabilities in the field of ImmunoDiagnostics.
The Prominent Key Players Operating in the India Allergy Diagnostics Market Include:
- Thermo Fisher Scientific Inc., (U.S.)
- Siemens Healthcare GmbH (Germany)
- Danaher (U.S.)
- Omega Diagnostics Group PLC (U.K.)
- bioMérieux (France)
- Romer Labs Division Holding (Austria)
- EUROIMMUN Medizinische Labordiagnostika AG (Germany)
- HollisterStier Allergy (U.S.)
- NEOGEN Corporation (U.S.)
- Eurofins Scientific (Luxembourg)
- Minaris Medical America, Inc. (U.S.)
- Stallergenes Greer (U.K.)
- HOB Biotech Group Corp., Ltd. (China)
- HYCOR Biomedical (U.S.)
- R-Biopharm AG (Germany)
- AESKU.GROUP GmbH (Germany)
- ACON Laboratories, Inc. (U.S.)
- Lincoln Diagnostics, Inc. (U.S.)
- Astra Biotech GmbH (Germany)
- Erba Group (U.K.)
Above are the key players covered in the report, to know about more and exhaustive list of India allergy diagnostics market companies contact, https://www.databridgemarketresearch.com/de/contact
Research Methodology: Global India Allergy Diagnostics Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
